Biobase Blood Coagulation Analyzer PT Aptt Tt Fib Coagulometer

Name: Biobase Blood Coagulation Analyzer PT Aptt Tt Fib Coagulometer
Brand: Biobase Biozone Co., Ltd.
SKU: 1912662075

Shandong, ChinaBiobase Biozone Co., Ltd.

US$400.00-530.00

1 Piece

Product profile

Customization

Available

Classification

Biochemical Apparatus

Type

Blood Coagulation Analyzer

Model NO.

BK-CA04

Group

All

Model

Bk-Ca04

Test Principle

Optical Colorimetry

Test Items

PT, Aptt, Tt, Fib

Test Channel

2 (Can Test Different Projects at The Same Time)

Wavelength

470nm

Sample Incubation Position

Reagent Incubation Position

Display

5-Inch High-Definition Color Touch Screen

Reaction Time

1-99s

Transport Package

Carton/Wooden Box or as Required

Trademark

BIOBASE

Origin

Shandong, China

Production Capacity

1000units/Month

Company profile

High Repeat Buyers ChoiceExhibition ExperienceMulti-language PioneerExperienced Team

Biobase Biozone Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 8 years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤2.97h

AI-Powered supplier vetting

SummaryThe supplier is identified as a combined company with eight production lines, reported annual productivity of 500,000 medical freezers, and two quality inspectors. It demonstrates broad customization and ODM capabilities, has introduced new products within the past year, and provides OEM services for well-known brands. Service procedures for supplier capability, corrective and preventive actions, and customer complaints are documented and supported by records. Overseas support includes installation, training, repair, debugging, and maintenance, with inventory and an overseas warehouse available. However, the supplier lacks overseas agents or branches, an overseas showroom, and a valid manufacturing-capacity contract with related subcontractors. Quality-control limitations include finished-product checks performed by packing staff and no continuous batch quantity reconciliation or outsourcing SOP. The supplied information does not establish certifications, financial strength, or specific customer case details.

Supplier typeThe supplier is explicitly classified as a combined company and is not an offshore company. The available information does not further define its ownership structure or operating model.

After-Sales capabilityThe supplier has documented procedures and records for handling customer complaints and corrective/preventive actions, and offers overseas installation, training, repair, debugging, and maintenance. It also reports inventory and an overseas warehouse, but has no overseas agents or branches and offers services in zero stated countries.

R&D capabilityThe supplier reports new products within the past year, provides ODM services, and supports multiple forms of design customization. ERP-based digital management is also reported, while no SDK is available; overall evidence supports product-development capability but not software-development capability.

Production capacityThe supplier reports eight production lines and annual productivity of 500,000 medical freezers, with inventory and overseas warehouse capability. Important controls are incomplete: there is no valid manufacturing-capacity contract with related subcontractors, no continuous batch quantity reconciliation, and no outsourcing SOP.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization, supported by stated R&D and ODM capabilities. This is direct evidence of broad customization coverage.